Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Efficacy of Denosumab in Patients With Thalassemia Major and Osteoporosis: A Randomized, Placebo-controlled, Single-site, Double Blind Phase 2b Clinical Trial

NCT02559648 is registered in ClinicalTrials.gov with Ersi Voskaridou as lead sponsor.

NCT NCT02559648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02559648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Efficacy of Denosumab in Patients With Thalassemia Major and Osteoporosis: A Randomized, Placebo-controlled, Single-site, Double Blind Phase 2b Clinical Trial
Lead sponsor
Ersi Voskaridou
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2014
Completion date
December 31, 2017
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis, thalassemia major